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Abstract The only documented activity of a subclass of
ADAMTS proteases comprising ADAMTS2, 3 and 14 is the
cleavage of the aminopropeptide of fibrillar procollagens. A
limited number of in vitro studies suggested that ADAMTS3
is mainly responsible for procollagen II processing in carti-
lage. Here, we created an ADAMTS3 knockout mouse
(Adamts3-/-) model to determine in vivo the actual functions
of ADAMTS3. Heterozygous Adamts3?/- mice were viable
and fertile, but their intercrosses demonstrated lethality of
Adamts3-/- embryos after 15 days of gestation. Procollagens
I, II and III processing was unaffected in these embryos.
However, a massive lymphedema caused by the lack of
lymphatics development, an abnormal blood vessel structure
in the placenta and a progressive liver destruction were
observed. These phenotypes are most probably linked to
dysregulation of the VEGF-C pathways. This study is the first
demonstration that an aminoprocollagen peptidase is crucial
for developmental processes independently of its primary role
in collagen biology and has physiological functions poten-
tially involved in several human diseases related to angio-
genesis and lymphangiogenesis.
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Introduction
ADAMTS (A Disintegrin And Metalloproteinase with
ThromboSpondin type 1 repeat) are secreted metallopro-
teases forming a family of 19 different members that share
an identical N-terminal domain organization [1]. By con-
trast, they can be characterized or classified in subfamilies
according to the presence of specific C-terminal ancillary
domains or on the basis of their activities or substrates.
Proteoglycanases (ADAMTS1, 4, 5, 8, 9, 15, 20) constitute
a super-clade of ADAMTS able to cleave various proteo-
glycans although they possess a variable C-terminal domain
organization [2]. ADAMTS13 is the only member reported
to cleave the von Willebrand Factor [3–5]. ADAMTS2, 3
and 14 are highly related enzymes with identical domain
organization, high sequence homology and shared ability to
process the aminopropeptide of fibrillar collagens, catego-
rizing them as ‘‘aminoprocollagen peptidases’’ [6].
Mutations in ADAMTS2 are responsible for a human-in-
herited disease, the dermatosparactic type of Ehlers–Danlos
syndrome [7, 8], characterized among other features by
severe skin fragility and easy bruising. These clinical hall-
marks are thought to result from the accumulation of type I
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and type III aminoprocollagen (collagen still retaining its
aminopropeptide), which hinders collagen assembly into
highly organized fibrils. Other significant findings relating to
potential functions are the relative resistance of Adamts2-/-
mice to liver fibrosis [9], the infertility of Adamts2-/-males
[10], the expression of ADAMTS2 by activated macro-
phages [11], its anti-angiogenic properties [12] and its
potential role in pediatric stroke [13].
In contrast to the extensive literature on ADAMTS2,
ADAMTS3 remains much less characterized. It efficiently
processes the aminopropeptide of procollagen II in vitro and
is specifically expressed in cartilage during embryogenesis
and adult life [14]. Previously, in situ hybridization (ISH)
analysis revealed that Adamts3 was also highly expressed in
specific regions of the developing mouse brain and in
connective tissues such as bone and tendon [14]. It was
therefore assumed that ADAMTS3 would be the main
aminoprocollagen peptidase during embryogenesis, which
would explain the apparent normal development of these
tissues in Adamts2-/- embryos. In experimental models,
ADAMTS3 was also recently shown to be able to activate
VEGF-C by proteolytic cleavage [15] through a yet poorly
characterized mechanism that probably involves also
CCBE1, a secreted protein containing a collagenous
domain. Indeed, CCBE1 is required for lymphangiogenesis
by its ability to stimulate the activation of VEGF-C [16, 17]
although having no proteolytic activity. It is not yet clear,
however, whether this putative VEGF-C activating property
of ADAMTS3 is physiologically relevant and restricted to
ADAMTS3 since the highly similar ADAMTS2 and 14
could potentially share this function in vivo.
The aim of the present study was to elucidate the physi-
ological roles of ADAMTS3 through Adamts3 gene inacti-
vation inmice.We show here that ADAMTS3 is dispensable
for aminoprocollagen processing until mid-gestation. It is,
however, critical for embryonic development since its defi-
ciency prevents the formation of the lymphatic network,
alters the function of placental blood vessels and drastically
impairs liver development, which finally induces embryonic
lethality. Our data demonstrate the central role of
ADAMTS3 during two vital developmental processes and
further show that the overlap of functions with ADAMTS2 is
less important than previously expected.
Results
Adamts3 inactivation leads to embryonic lethality
with skin edema and impaired liver development,
but procollagen processing is not altered
A mouse strain allowing the Cre-mediated conditional
removal of the exon 8 to exon 10 Adamts3 gene sequence
was created. At the protein level, the skipping of these
exons results in the absence of the catalytic metalloprotease
domain, which prevents the possibility of any residual
enzymatic activity, and introduces a frameshift by chang-
ing the Adamts3 ORF (Fig. S1). It is worth mentioning also
that this short genomic region does not contain any
described miRNA or long noncoding RNAs. These mice
were crossed with mice expressing Cre globally, including
in the germ lines, in order to produce mice with a single
functional Adamts3 allele (Adamts3?/-). The shorter
mRNA produced from the targeted allele was RT-PCR
amplified and sequenced, confirming both the specific
skipping of exons 8–10 and the reading frameshift of the
mRNA. Adamts3?/- mice were crossed, but no Adamt-
s3-/- neonates were observed in the litters, suggesting
embryonic lethality. Genotyping of embryos at various
development stages demonstrated that Adamts3-/-
embryos died around E15.0 and that the expected ratio
between Adamts3?/?, Adamts3?/- and Adamts3-/- was
Mendelian at earlier stages [25:56:19 % for E13–13.5
(n = 113) and 21:56:23 % for E14–14.5 (n = 281),
48:46:6 % for E15–15.5 (n = 31)].
At E12.5, the gross morphological appearance of
Adamts3?/?, Adamts3?/- and Adamts3-/- embryos was
similar, whereas Adamts3-/- embryos could be identified
at E13.5 by the presence of edema in the dorsal skin. Skin
edema and a paler color were striking in E14.5 Adamts3-/-
embryos (Fig. 1a), as well as a reduction in liver size as
observed after dissection (Fig. 1b). General examination of
H&E-stained sections confirmed the progressive develop-
ment of edema in Adamts3-/- embryos from E13.5 to
E14.5 and the reduction in liver size, while the other tissues
and organs did not seem to be significantly affected
(Fig. 1c).
Another relevant alteration was observed in blood-rich
regions (heart, aorta, large blood vessels). At E14.5, the
ratio of nucleated/nonnucleated red blood cells (RBC) was
higher in Adamts3-/- embryos and was confirmed on
blood smears (Fig. S2). This observation further supported
liver dysfunction, since the liver becomes the dominant
hematopoietic organ at this developmental stage and pro-
duces nonnucleated RBC, while RBC produced earlier in
the yolk sac are nucleated.
Since the best described substrates of ADAMTS3 are
fibrillar procollagens [18], potential processing defects
were therefore evaluated by Western blotting. Adamts2-/-
embryos were used for comparative purposes. As com-
pared to WT, defects in the processing of the amino-
propeptide of type I collagen was evident in Adamts2-/-,
but not in Adamts3-/- embryos (Fig. 2a), showing that
ADAMTS2, and not ADAMTS3 as previously thought, is
the main type I aminoprocollagen peptidase during
embryogenesis. Regarding type II and type III collagens,
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the pattern was similar in the three genotypes, which
suggested that ADAMTS2, ADAMTS3 and potentially
ADAMTS14 would be capable of compensating their
respective absence. The accumulation of type II collagen
(not shown) and the formation of cartilage (Fig. 2b) were
identical in Adamts3?/? and Adamts3-/- embryos.
Abnormal lymphangiogenesis
Because skin edema was the first visible phenotype in
Adamts3-/- embryos, we first focused our attention on
cutaneous lymphatics using superficial sagittal sections.
Blood vessels and lymphatics were present in the skin of
Adamts3?/? embryos (Fig. 3a, b). A comparable number of
veins and arteries were seen in the Adamts3-/- skin sam-
ples, but not a single lymphatic was identified (Fig. 3d).
Full-thickness whole mounts of the dorsal skin were also
evaluated after immunofluorescence labeling of blood
vessels (CD31, in red) and lymphatics (VEGF-R3, in
green). The blood vessel network was similar in Adamt-
s3-/- and Adamts3?/? embryos (Fig. 3c, e; see also Fig. S3
for additional pictures). In sharp contrast, while VEGF-R3-
positive dermal lymphatic vessels were clearly visible in
control embryos, none was observed in Adamts3-/- skin,
in agreement with immunohistochemical data.
Another highly specific and localized area where lym-
phatics can be clearly identified is the intercostal neu-
rovascular bundle formed by a vein, an artery, a nerve and
very often a lymphatic at that embryonic stage (Fig. 3f–h).
Only veins, arteries and nerves were observed in the
Adamts3-/- embryos (Fig. 3i, j), further confirming the
critical role of Adamts3 in lymphangiogenesis.
Since VEGF-C is a crucial growth factor for lymphatic
formation and in line with recent data [15], we used a
model of cotransfection to evaluate the ability of Adamts3
to activate ‘‘pro-VEGF-C.’’ As illustrated in Fig. 4, we
found that Adamts3 promoted the activation of VEGF-C,
even in the absence of recombinant CCBE1. Using the
same model, Adamts2 and Adamts14 were not able to
activate VEGF-C in the presence or absence of CCBE1
(not shown). VEGF-C is similarly expressed in Adamts3?/?
and Adamts3-/- embryos, as judged from qRT-PCR (not
shown). Crude tissue extracts were also analyzed by
Western blotting, an approach that turned out to be not
sensitive enough to allow the detection of VEGF-C, either
as pro-form or as the fully activated form (not shown). An
enrichment protocol using soluble VEGF-R3 as bait was
therefore designed to determine the activation status of
VEGF-C in these embryos. Despite the fact that control
samples (tissue extract supplemented with 10 ng of
recombinant mouse VEGF-C) were positive, again no
Fig. 1 Characterization of
Adamts3-/- embryos. a General
morphology of Adamts3?/? and
Adamts3-/- embryos at E14.5.
Pale color, skin edema (red
lines) and smaller liver (L) are
evident in Adamts3-/- embryos.
b General morphology of
Adamts3?/? and Adamts3-/-
livers from E14.5 embryos.
Stomach (S) and liver (L) are
indicated as well as degradation
zones of the liver (yellow
arrows). c Sagittal sections of
whole embryos at E14.5 and
E13.5 were stained with H&E,
illustrating skin edema in E14.5
and E13.5 Adamts3-/- embryos
(red lines). Reduction in liver
(L) size and the presence of
localized altered liver zones
(arrow) are visible at E14.5
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VEGF-C signal could be observed in experimental sam-
ples. Based on the reported active concentration range of
VEGF-C in blood and in the extracellular compartment
(0.1–2.5 ng/ml), the total amount of VEGF-C in the entire
embryo (embryo weight\ 300 mg) is most probably lar-
gely under the detection limit by Western blotting.
Hepatic architecture deteriorates after E13.5
Before E13.0, liver histology was comparable in the
Adamts3?/? and Adamts3-/- embryos. By E13.5, a few
abnormal swollen cells systematically appeared in highly
localized ventral areas of Adamts3-/- livers (compare
Fig. 5a, b). At E14.5, stronger alterations were apparent
(Fig. 5c, d), which suggested a progressive spreading from
the initial lesion.
Sections of whole embryo were further characterized by
immunohistochemistry and immunofluorescence, with a
more specific focus on the liver. In Adamts3?/? embryos,
very few hepatic cells were apoptotic (cleaved caspase
3-positive staining) (Fig S4A), while Adamts3-/- livers
were characterized by a strong positivity in the ventral
portion of the lobes, which progressively enlarged from
E13.5 to E14.5. Diffuse labeling through the entire liver
was never observed. KI67 staining of proliferating cells
was similar in all the tissues of the three genotypes, except
in the affected zones of the liver (Fig. S4B). Of special
interest, blood vessels appeared enlarged in the ventral part
of the liver lobes (Fig. S4C), even before the first clear
signs of apoptosis.
In light of the observed skin and liver damages, RNA
ISH using a new and sensitive method was used to re-
evaluate the distribution of Adamts3 mRNA in embryos at
E13.5 and E14.5. As previously identified, strong expres-
sion was seen in specific regions of the central nervous
system, craniofacial region and limbs (Fig. S5A) and in
cartilage of the ribs (Fig. S5B). Expression of Adamts3 was
also detected at E13.5, although at a lower level, in dermal
mesenchyme of skin (Fig. S5C) but only in scattered liver
cells (Fig. S5D). RT-PCR amplification was also per-
formed as an additional control to confirm Adamts3
expression in the liver and the ‘‘body.’’ Products of
expected size were obtained for both tissues (Fig. S5E),
with a relative expression correlating with the ISH data.
Transcriptome analyses
In an attempt to identify the pathway(s) affected in
Adamts3-/- liver, microarray analyses were performed
using hepatic tissues of E13.5 to E14.5 embryos in order to
determine the early and late events affected by Adamts3
deficiency (ArrayExpress: E-MTAB-2614). The reliability
of the transcriptomic data was confirmed by RT-PCR
(Fig. S6).
At E13.5, only Esm1 and Xlr4a were significantly
upregulated ([2) in Adamts3-/-, while 8 of the 11 repressed
Fig. 2 Fibrillar procollagen processing and cartilage visualization in
Adamts3-/- embryos. a Connective tissue (body without head and
viscera) of wild-type Adamts2-/-and Adamts3-/-embryos at E14.5
was homogenized and analyzed by Western blotting using antibodies
specific for procollagens I, II or III. Modification of the levels of
processed and unprocessed collagens was only seen for type I
collagen in Adamts2-/- tissue. pCa: procollagen a chain; pNa:
collagen a chain still retaining the amino-terminal extension; a: fully
processed a chain. b Sections of Adamts3?/? and Adamts3-/-
embryos were stained with Alcian blue to identify cartilage (scale bar
2 mm)
56 Angiogenesis (2016) 19:53–65
123
genes (Ear2, 3, 4, 6, 10, 12; Prg2/MBP-1; Prg3/MBP-2)
were related to the eosinophil lineage (Table S1). At E14.5,
the number of upregulated or downregulated genes dra-
matically increased in agreement with the deep deteriora-
tions occurring in the liver just before embryonic death. As
these massive modifications hampered the identification of
the primary causes of the phenotype, we focused our
attention on genes significantly expressed ([200 A.U.) in at
least two samples and characterized by a consistently pro-
gressive increased or decreased expression correlating with
the severity of the alterations observed in Adamts3-/- livers.
This filtering provided a limited number of genes that were
all characterized by a progressively increased expression
(Table 1; S2). A majority of these genes were related to one
or two of the following categories: ‘‘connective tissues,’’
‘‘angiogenesis,’’ ‘‘inflammation,’’ ‘‘signaling pathways’’ and
‘‘glucose metabolism.’’ The earliest and most upregulated
gene was ESM1, a marker of activated endothelial cells. Flt1
(VEGF-R1) and VEGF-A, two other factors regulating
angiogenesis, were also upregulated. The most abundant
group (glucose metabolism) comprised factors directly
involved in glycolysis, glucose uptake (Glut3/Slc2a3) and
intracellular signaling pathways regulating glucose meta-
bolism (Trib3 and Egln3/Phd3, the second and third most
upregulated genes after ESM1). Although the fold change
remained moderate for some enzymes and factors, the
overrepresentation of this well-defined category (20 out of
89 transcripts) was striking.
Although many genes and categories identified by
transcriptomic analyses were known targets of the TGFb
pathways, no significant modification of the mRNA level
of TGFb was identified. A significant increase in TGFb1
Fig. 3 Normal angiogenesis but absence of lymphatics in Adamt-
s3-/- embryos. Superficial sagittal sections in the skin of wild type
(Adamts3?/?) (a, b) and Adamts3-/- (d) E14.5 embryos were stained
using antibodies specific to prox-1 (a) or Lyve-1 (b, d). While many
lymphatics were identified in Adamts3?/? skin, they were never
observed in Adamts3-/-. V vein, L lymphatic, M macrophage. Full-
thickness whole mounts of Adamts3?/? (c) and Adamts3-/- (e) dorsal
skin were immunostained to identify blood vessels (CD31, in red) and
lymphatics (VEGF-R3, in green). Lympatics were observed only in
Adamts3?/? skin (see also Fig S3 for individual pictures and
additional data). Sections at the border between the thoracic cavity
and the rib cage (f–j) were also stained with H&E (f, g, i, j) or using
an anti-prox-1 antibody (h). Enlarged views of the boxed regions in f,
i are shown in g, j, respectively. Prox-1 staining (h) of the section
following the section in f is also provided. Nerve (N), artery (A) and
vein (V) are seen in Adamts3?/? and Adamts3-/-. Lymphatics (L) are
often seen in Adamts3?/? but never in Adamts3-/-
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was, however, observed by Western blotting in crude
extracts of Adamts3-/- livers at E14.5 (Fig. S7). The
potential implication of TGFb1 in the phenotype was
therefore investigated by IHC staining of phospho-Smad2
and phospho-Smad3 in liver sections, but no clear differ-
ence between Adamts3?/? and Adamts3-/- samples could
be identified, which suggested that TGFb1 accumulation
was not the main cause of liver apoptosis.
Blood vessels are altered in the placenta
of homozygous mutants
Since many genes upregulated in Adamts3-/- livers were
linked to hypoxia and glycolysis, we made the hypothesis
that it might be related to placenta alterations that would
result in insufficient oxygen and nutrient supply to the
embryo. RT-PCR amplifications showed that Adamts3 is
expressed in placenta. RNA ISH was next used to identify
cells expressing Adamts3. Only a limited number of tro-
phoblastic cells were faintly positive, and the strongest
staining was observed in the chorionic plate (Fig. 6a, b; see
also Fig S8). Positivity was also observed in the labyr-
inthine layer but mainly around large vessels and along
structures looking like small blood vessels (Fig. 6c, d),
which suggested that mesodermal/mesenchymal cells are
the main producers of Adamts3.
HE-stained sections looked quite similar in Adamts3?/?
and Adamts3-/- placentas (Fig. 7a, b), except for the
presence, in some regions of Adamts3-/- placenta, of an
increased number of fetal blood vessels that were full of
nucleated red blood cells and that seemed too narrow to
allow free flow (Fig. 7c). This observation was confirmed
by CD31 (Fig. 7d–f) and basement membrane (collagen
type IV, Fig. S9 A–C) staining. The mean diameter of the
blood vessels was also determined with the NDP software
Fig. 4 Activation of the intermediate form into the fully active form
of VEGF-C by ADAMTS3. HEK293 cells were transfected with an
empty vector (Ctr) or with an expression vector containing the
complete coding sequence of VEGF-C (lanes 2–5). In some
conditions, cells were simultaneously transfected with expression
vectors for CCBE1 (3, 5) and/or ADAMTS3 (4, 5). Culture media
were collected after 48 h and analyzed by WB. Conversion of the
intermediate processed form of VEGF-C (31 kDa) into its mature
form (21 kDa) is observed in the presence of CCBE1 alone and is
almost complete in the presence of ADAMTS3
Fig. 5 Evaluation of Adamts3-/- liver defects. Photomicrographs of
HE-stained sections of whole embryos (Adamts3?/? a, c; Adamts3-/- b,
d) at E13.5 (a, b) and E14.5 (c, d) were taken in identical regions at
increasing magnifications. Hepatoblasts (yellow arrows) appear as light
purple cells containing a large,weakly stainednucleus.A largeproportion
of blood cells (red blood cells and small rounded cells with a strongly
stained nucleus) are also visible throughout the parenchyma. At E13.5,
some hepatocytes in focal areas of Adamts3-/- livers are swollen (B3),
while they seem normal at short distance. At E14.5, no hepatoblasts are
still present in the center of the lesions and only a reduced number are
visible at the periphery, whereas many blood cells are still present
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(Hamamatsu) on four pairs of placenta from four different
litters (Table S3, see legend for quantification details). A
slight but significant reduction (14 %, p\ 0.01) in the
vessel diameter was found in Adamts3-/- (8.6 ± 0.7 l,
n = 799) as compared to Adamts3?/? (10.0 ± 0.6 l,
n = 1078). It is worth noting that in 2 litters the number of
measurable vessels with a patent circular lumen was
reduced in the Adamts3-/- placenta, which suggested that
some vessels had already collapsed and were not taken into
account. Cross sections were further realized in the center
of placenta from three different litters (3 Adamts3-/- and 5
Adamts3?/?) in order to evaluate the respective thickness
of the labyrinthine and the spongiotrophoblast layers,
which can be easily discriminated by CD31 staining of the
vessels containing the embryonic blood (Fig. 7g–i;
Fig. S10). The mean total surface of the two layers was
identical in the two genotypes (7.3 ± 1.5 mm2 in Adamt-
s3-/- vs 7.1 ± 0.9 mm2 in Adamts3?/?). However, the
Table 1 Main functional categories of genes identified by microarray analysis as characterized by a progressive increased or decreased
expression correlating with the severity of liver alterations
Angiogenesis Egln3/PHD3, Eif4ebp1, Esm1, Flt1, Pecam/CD31, Vegf-a
Connective tissues Adamts2, Col1a1, Col5a1, Col6a1, Col6a3, Ctgf, Lamc1, Lgals3, P4ha2
Glucose metabolism/
glycolysis
Adh1, Aldoa, Gtl2, Egln3/PHD3, Egr1, Eno, Fam132b, Gapdh, Gpi1, Grhpr, Ldha, PDK1, PFKl, PFKp, PKM2,
Pgam1, Pgk1, Slc2a3/Glut3, Stat3, Tpi, Trib3
Inflammation Ctgf, Ctsg, Cxcl1, Cxcl10, F13a1, Mpo, Nfkbiz, S100a9, Stat3, Vav1, Lcn2
Signaling pathways Cebpb, Ctgf, Cxcl1, Cxcl10, Dusp6, Egln3/PHD3, Egr1, Ets2, Gata6, Junb, Mapkapk3, Mt2, Stat3, Trib3, Vav1
See Table S2 for the complete list and values
Fig. 6 Evaluation of Adamts3 expression in mouse placenta. Sec-
tions of E12.5 placenta were hybridized with Adamts3 probes (see
Fig. S8 for additional details) and counterstained with Gill’s
hematoxylin. Nuclei are stained in blue, and the expression of
Adamts3 is revealed by the presence of red dots. The strongest
Adamts3 expression was observed in the chorionic plate (a, b), the
structure where large embryonic vessels (asterisk) enter the placenta.
Nucleated erythroblasts are marked by arrows. Positivity is also
observed in the labyrinthine layer, mainly around large vessels (c) and
along structures looking like small blood vessels (arrowheads in d).
Only a limited number of trophoblastic cells, identified by their very
large nucleus, are faintly positive. CP chorionic plate, L labyrinthine
layer. Scale bars 50 lm
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Fig. 7 Immunohistologic
analysis of placental blood
vessels. Transverse sections
were performed in E14.5
placenta (Adamts3?/? in a, d, g,
j; Adamts3-/- in b, c, e, f, h, i,
k). All the pictures were taken
in the labyrinthine layer where
the blood vessels containing
embryonic blood are present.
After H&E staining (a–c), the
structure of the Adamts3-/-
placenta seemed grossly normal
(compare b to a), except for the
accumulation of nucleated
erythroblasts in some vessels
(c). CD31 staining (d–f) showed
a normal pattern of blood vessel
distribution in Adamts3-/-
placenta but suggested some
reduction in vessel diameter (d–
f). Transverse sections were also
performed in the middle of other
placenta (Adamts3?/? in g; two
different Adamts3-/- placenta
in h and i; see also Fig. S10 for
additional data). At low
magnification, the labyrinthine
layer (L delineated by yellow
lines) is clearly identified by its
high blood vessel density. Its
surface is significantly reduced
in Adamts3-/- placenta.
Immunofluorescence staining (j,
k) showed that blood vessels are
formed by cells with different
levels of expression of CD31
(green) and VEGF-R3 (red). No
difference was found between
Adamts3?/? and Adamts3-/-
samples. Bars 50 lm in a–f and
300 lm in g–i. CP chorionic
plate, S spongiotrophoblast
layer
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specific surface occupied by the labyrinthine layer was
significantly reduced in Adamts3-/- placenta (48.8 ± 3.3
vs 62.3 ± 2.0 % in Adamts3?/?).
In order to investigate why the blood vessels are not
damaged in the Adamts3-/- embryos while angiogenesis is
modified in their placenta, we evaluated the potential
expression of VEGF-R3 in placenta blood vessels. As we
previously showed (Fig. 2c), VEGF-R3 staining was absent
from blood vessels in E14.5 embryos. By contrast,
endothelial cells in the placenta were positive for VEGF-
R3, irrespective of the genotype (Fig. S9 D–F), which
would explain why Adamts3-/- placental vessels are
affected, while vessels in the embryo are not. Faint staining
of trophoblast clusters in the labyrinthine layer was also
observed. Immunofluorescence studies further showed that
almost all the blood vessels in the labyrinthine layer were
formed by endothelial cells expressing VEGF-R3 and/or
CD31, in both Adamts3?/? and Adamts3-/- placentas
(Fig. 7j, k).
Discussion
It was initially considered that the function of ADAMTS3
was exclusively or primarily related to procollagen pro-
cessing [14, 18]. We developed an Adamts3 knockout
mouse model to evaluate this hypothesis and to identify
potential additional functions in vivo. Mice with a single
inactive allele (Adamts3?/-) were fertile, but their mating
did not produce Adamts3-/- pups because of lethality
occurring around the E15.0 period. The processing of the
main fibrillar collagens (types I, II and III) and their tissue
localization were similar in Adamts3-/- and Adamts3?/?
embryos, demonstrating that the strong expression of
ADAMTS3 during embryonic development and the
observed phenotypes in Adamts3-/- embryos were not
discernibly related to collagen biology. Two main pheno-
types were observed in Adamts3-/- embryos. Cutaneous
lymphedema was striking and caused by the absence of
lymphatics normally developing in the dorsal skin around
E13.0–E13.5. Liver degeneration was also remarkable. It
started around E13.5 in strictly localized ventral regions of
Adamts3-/- livers and then rapidly spread from this initial
spot. The vast majority of the other mouse models of
embryonic lymphedema do not display liver pathology [19,
20], and conversely, mouse strains characterized by severe
hepatic alterations during embryogenesis do not display
concomitant edema [21–24]. However, there is one gene
for which deficiency leads to a phenotype displaying many
similarities with the Adamts3-/- phenotype. CCBE1
(Collagen- and Calcium-Binding EGF domain-containing
protein 1) is mutated in a cohort of patients with Hennekam
syndrome who present abnormal lymphangiogenesis [25].
In the mouse, Ccbe1 deficiency leads to embryonic
lethality, edema and liver hypoplasia [17, 26]. As in
Adamts3-/- embryos, lymphedema is massive and simi-
larly characterized by the absence of lymphatics normally
forming around E13–E13.5. CCBE1 is required for lym-
phangiogenesis because it increases the processing of pro-
VEGF-C into its fully active form able to stimulate VEGF-
R3 phosphorylation and downstream signaling [16]. Very
recently, it was shown in experimental models that
CCBE1, although lacking intrinsic enzymatic activity,
facilitates pro-VEGF-C activation by ADAMTS3, but not
by its closest relatives ADAMTS2 and ADAMTS14 [15]. It
was not clear, however, whether ADAMTS3 is required in
physiological conditions or whether other proteases could
be involved in vivo. Our data clearly demonstrate that
ADAMTS3 is indispensable for embryonic lymphangio-
genesis, which is most likely related to its capacity to
activate VEGF-C.
While the lymphatic phenotype is identical in Adamt-
s3-/- and Ccbe1-/- embryos, some similarities and dif-
ferences were evidenced for liver. Hepatic alterations
appear in both genotypes around E13.0–E13.5 [26]. This is
accompanied by a marked increase of the nucleated/enu-
cleated erythrocytes ratio in the blood stream, which is
likely caused by hepatic disorders since the liver becomes
the most important organ for erythropoiesis at mid-gesta-
tion. In Ccbe1-/- embryos, however, the pattern of apop-
tosis was not reported to be as localized as seen in
Adamts3-/- and the reduction in the liver size was attrib-
uted primarily to altered erythropoiesis [26], whereas
hepatoblasts are amongst the first dying cells in Adamt-
s3-/- embryos. Another specific observation in Adamt-
s3-/- livers was the enlargement of blood vessels
surrounding the apoptotic area, even at E13.5 when the
hepatic lesion is still highly localized to a limited number
of cells.
Transcriptome analyses were performed on strongly
(E14.5), mildly (E14.0) or almost unaffected (E13.5)
livers in order to identify the molecular mechanism
leading to apoptosis in the hepatic tissue. We focused our
attention on genes characterized by a progressive
increased or decreased expression correlating with the
severity of the liver alterations observed in Adamts3-/-
embryos. Categories related to ‘‘connective tissues,’’
‘‘angiogenesis,’’ ‘‘glucose metabolism’’ and ‘‘inflamma-
tion’’ were identified. Several secreted or intracellular
factors related to cell regulation (‘‘signaling pathway’’)
were also upregulated, some of them (Trib3, CTGF/
CCN2, Egr1, Stat3…) having been linked to inflamma-
tion, tissue repair, liver fibrosis and TGFb signaling [27,
28]. Since Tgfbr3-/- embryos are not viable and display
hepatic defects at mid- to late gestation [22], the impli-
cation of the TGFb pathway was investigated. As
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compared to their control littermate, accumulation of
TGFb1 was specifically found in the liver of Adamts3-/-
embryos. However, this was not accompanied by
increased phosphorylation of Smad2 or Smad3, which
suggested that abnormal regulation of the TGFb pathway
was not the main cause of the hepatic phenotype. We next
focused our attention on the categories of genes involved
in ‘‘Angiogenesis’’ and in ‘‘Glucose metabolism/glycol-
ysis’’ pathways. A common characteristic of many of
these genes is that they are directly (ESM1, VEGF-R1,
VEGF-A, PHD3) or indirectly (glycolysis enzymes,
transcription factors regulating metabolic activity, such as
Egr1 and Trib3) responsive to hypoxia or deprivation of
nutrients. Since blood vessels looked normal in embryos
with no obvious sign of leakage or hemorrhage, we rea-
soned that the primary defect might reside in the placenta,
a tissue allowing O2 and nutrient exchanges between the
maternal and the fetal blood. In line with this hypothesis,
it was previously shown that HGF deficiency causes
placental defects that secondarily lead to a specific pattern
of liver apoptosis always initially localized in the ventral
part of the lobes, most probably because this area is at the
extremity of the liver blood vessel network and therefore
the most sensitive to oxygen supply and hypoxia [29, 30].
Tissue staining showed that the labyrinthine layer con-
taining the embryonic blood is reduced in Adamts3-/-
placenta and that the CD31-positive vessels have a
reduced diameter as compared to the Adamts3?/? controls
(8.6 vs 10.0 lm). Although this reduction is modest, it can
be hypothesized to be functionally significant because
nucleated erythroblasts that predominate in Adamts3-/-
embryo have an 8- to 9-lm mean diameter. In these
conditions, even a small reduction in size is expected to
restrict the bloodstream and, combined with a thinner
labyrinthine layer, to result in a reduced oxygenation of
the embryo. Since the embryonic liver is highly metabolic
and at the limit of hypoxia during normal development,
especially at the extremity of its vascular bed in the
ventral parts of the lobes, it was not surprising to observe
hypoxic markers only in the liver. This hypothesis is
further strengthened by our observations, showing that
blood vessels are enlarged in the ventral part of the lobes
before the first clear signs of hepatic destruction. In the
mutant embryos, reduced blood volume due to lym-
phedema and reduced vessel diameter in the placenta
would act synergistically to lower nutrients and oxygen
delivery to the embryo, which would primarily affect the
liver and would further compromise oxygenation by
reducing the formation of mature erythroblasts in the
liver. This combination of events would explain why a
Mendelian proportion of Adamts3-/- embryos was
observed before E14.5, while most of them were dead
after E15.0.
The expression of VEGF-R3 in endothelial cells form-
ing placental capillaries further illustrates that the
ADAMTS3/VEGF-C/VEGF-R3 pathway is critical for
placenta blood vessel at this embryonic stage. In this
context, it would be interesting to characterize the blood
vessel structure in the Ccbe1-/- placenta. It is worth
mentioning also that Ccbe1 deficiency is less severe
(lethality at E16.5) [17] than inactivation of Adamts3
(lethality at E15.0). It will have to be determined whether
this is related to the fact that pro-VEGF-C processing by
ADAMTS3 occurs in the absence of Ccbe1, although with
a reduced efficacy, while the reverse is not true. Alterna-
tively, it could be hypothesized that the more severe phe-
notype in Adamts3-/- results from other functions
(procollagen processing, TGFb pathway) that would per se
only modestly affect embryos but that would synergize to
aggravate the VEGF-C-related phenotype.
This study is the first demonstration that an amino-
procollagen peptidase is involved in collagen-indepen-
dent processes in physiological conditions. We demon-
strated that ADAMTS3 is required for embryonic
lymphangiogenesis and placenta angiogenesis. These
data identify ADAMTS3 as a candidate gene for genetic
diseases characterized by lymphedema and/or placenta
defects. Since total absence of ADAMTS3 in humans
would likely lead to miscarriage, only hypomorphic
mutations may be observed in genetic lymphedema. It
would be most interesting also to evaluate whether
ADAMTS3 is also involved in lymphatics homeostasis
during the adulthood and in the abnormal lymphangio-
genesis observed in several pathological conditions,
including cancer and metastasis dissemination. The
expression of ADAMTS3 in the brain and the implication
of the VEGF-C/VEGF-R3 pathway in the activation of




Mice were maintained under standard laboratory condi-
tions, with 12-h light/12-h dark cycles and free access to
food and water. All procedures were performed in accor-
dance with the guidelines for animal care of the University
of Lie`ge, the Federation of European Laboratory Animal
Science Associations and the American National Institutes
of Health.
Genotyping of tail DNA was performed with KAPA
Express Extract Kits (KAPA Biosystems, USA) using the
following primer pairs: P1–P2 for wild-type allele; P3–P2
for the targeted allele; P4–P2 for the deletion of the Neo
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cassette inserted into intron 10; P5–P6 for Flp recombinase
(Table S4).
The gestational age of embryos was determined from a
vaginal plug, corresponding to 0.5 days postcoitum (E0.5).
Pregnant females were killed by cervical dislocation and
decapitation according to institutional guidelines. The
uterus was removed and washed with physiological saline.
Embryos were dissected free of decidual tissue and washed
to remove contaminating maternal blood. After removal of
the placenta, embryos were rinsed in saline, exsanguinated
by separation of the vitelline and umbilical vessels and
allowing blood to drain. Blood was smeared on glass slide
and air-dried for May–Grunwald–Giemsa staining.
Immunohistological analyses
Embryos or dissected organs were fixed in a 4 %
paraformaldehyde (PFA) solution. Paraffin-embedded tis-
sue sections (5 lm) were deparaffined and rehydrated.
Tissue sections were stained with hematoxylin/eosin for
general histology or with alcian blue (GURR, UK) for
cartilage.
Fibrillar collagen was stained with antibodies against
Col I [a1(I), 234167, Calbiochem, Germany], Col II
[a1(II), SAB4500366, Sigma, USA] and Col III [a1(III),
in-house developed guinea pig serum]. Blood and lym-
phatic vessels were identified using, respectively, anti-
CD31 (Dia310, Dianova, Germany) or antibodies against
LYVE1 (07-538, Upstate, USA), Prox1 (AF2777, R&D
Systems) and VEGF-R3 (AF743, R&D Systems). The
other antibodies were from AbD Serotec (F4/80,
MCA497BB, AbD Serotec, UK), Cell Signaling Tech-
nology (USA) (Cleaved Caspase-3, 9664), Dako (Den-
mark) (Ki67, M7246) or Abcam (UK) (TGFb1,
ab66043).
In situ hybridization
Placenta and mouse embryos were fixed overnight in 4 %
paraformaldehyde/PBS, embedded in paraffin and sec-
tioned (6 lm). In situ hybridization was carried out using
the RNAscope technique and custom-designed in situ
hybridization probes (RNAscope 2.0; Advanced Cell
Diagnostics, Hayward, CA) according to the manufac-
turer’s instructions. Target probes were detected using an
alkaline-phosphatase-conjugated labeled probe with Fast
Red as substrate and Gill’s Hematoxylin as a counterstain.
As a negative control, some sections were hybridized with
target probe against DapB, a bacterial gene encoding
dihydrodipicolinate reductase. A target probe directed
against ubiquitously expressed Polr2a served as a positive
control. The slides were then counterstained according to
the manufacturer’s protocol with Gill’s hematoxylin and
treated with ammonium water before mounting. In these
conditions, nuclei are stained in blue and the expression of
Adamts3 is revealed by the presence of red dots.
Staining of blood and lymphatic vessels in whole
mount skin
Whole embryos were fixed for 1 h in 70 % ethanol. The
dorsal skin was then dissected and postfixed overnight in
4 % PFA. The samples were washed twice in PBS con-
taining 0.2 % Triton X-100 (PBT) 30 min at 4 C and
blocked for 1 h in PBT containing 1 % BSA at RT. To
perform double immunostaining, primary antibody against
CD31 (at 1/150) and VEGF-R3 (at 1/50) (AF743, R&D
Systems, USA) was diluted in PBT/BSA and incubated
overnight at 4 C. After three washings of 30 min in PBT
at 4 C and two at RT, the skin samples were incubated
overnight at 4 C with Alexa 488 anti-goat (1/1000 in PBT/
BSA) and Alexa 546 anti-rat (1/1000) (Invitrogen, USA).
After washing (as above), samples were mounted on glass
plates with Aquapolymount (PolySciences Inc., USA) and
observed with a Leika SP5 confocal microscope, adapted
from [32].
Western blotting
Liver and ‘‘body’’ (connective tissue remaining after
careful removal of the head and viscera) were dissected,
ground at liquid nitrogen temperature, homogenized in
Laemmli denaturation buffer (with or without 100 mM
DTT) and denatured (95 C, 5 min). After electrophoresis
(7.5–12.5 % SDS-PAGE), proteins were transferred onto a
polyvinylidene difluoride membrane (NEN Life Sciences
Products, USA). Membranes were blocked with 3 % BSA
in PBS-Tween and were probed with a rabbit antiserum
directed against type I, type II or type III collagens, or
against TGFb1. The secondary peroxidase-conjugated
antibodies were swine anti-rabbit or rabbit anti-guinea pig
immunoglobulins (1/2000, Dako). Peroxidase was revealed
with an enhanced chemiluminescence assay (Pierce, USA)
and X-ray film (Kodak, USA) exposure.
Microarray analysis
RNA was extracted with NucleoSpin RNA/protein kit
(Machery-Nagel, Germany) according to the manufac-
turer’s instructions. The RNA quality was evaluated with
Eukaryote Total RNA Nano Assay of the Agilent 2100
Bioanalyzer (USA). Transcriptome analyses were per-
formed on Illumina Mouse WG-6 v2.0 chips on total RNA
from the liver of Adamts3?/? and Adamts3-/- littermates
between E13.5 and E14.5. The raw data were analyzed
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using the GeneChip Operating software. Additional anal-
yses were also performed with Ingenuity Pathway (Qiagen,
USA) or DAVID software [33].
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